BRIEF-Ipsen announces data presentations at 2016 ESMO congress
September 27, 2016 at 12:04 PM EDT
* Ipsen announces data presentations of Cabozantinib, Lanreotide and Telotristat Ethyl at the european society for medical oncology (ESMO) 2016 congress Source text for Eikon: Further company coverage: (Gdynia Newsroom)
